Patients with low level of circulating CD34+ cell in CVD and CKD patients on chronic hemodailysis have lower survival rather than higher CD34+ group.
The question is that how to improve survival of CVD and CKD patients on chronic hemodailysis with lower level of CD34+ cell?
with regards,